HR 1922

Summary

Ensuring Access to Essential Drugs Act This bill exempts certain brand-name drugs from the Medicare Part D Manufacturer Discount Program. Under the program, drug manufacturers provide discounts to beneficiaries who have incurred costs above the annual deductible under the Medicare prescription drug benefit. Specifically, the bill exempts from the program orally administered, brand-name drugs that are considered generics for purposes of the Medicaid Drug Rebate Program (per an exception granted by the Centers for Medicare & Medicaid Services).

Bill status

Status

In committee

Sponsor

Rep. Andrew R. Garbarino [R-NY-2]

Cosponsors

2

Policy area

Health

Introduced

2025-03-06

Latest action

2025-03-06: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committee referrals

• Ways and Means Committee: House · Referred To · 2025-03-06
• Energy and Commerce Committee: House · Referred To · 2025-03-06

Recent actions

• 2025-03-06: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2025-03-06: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
• 2025-03-06: Introduced in House
• 2025-03-06: Introduced in House